Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Delsys to develop oral formulations of Parke-Davis drugs

May 4, 1998

Progenitor receives patent protection for stem cell technology

May 4, 1998

NeoRx receives SBIR grant for development of Pretarget technology

May 4, 1998

Improved gastrointestinal delivery of heparin with SNAC

May 1, 1998

Genetronics begins phase II trial of electroporation therapy in U.S.

May 1, 1998

CV Technologies reveals ChemBioPrint technology

April 29, 1998

Xoma licenses protein production technology to Invitrogen for research use

April 29, 1998

Abgenix, Genentech form research collaboration

April 29, 1998

Theratechnologies and Genetix enter strategic alliance

April 28, 1998

Genometrix and GeneMedicine embark on high-throughput screening effort

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...